LANITOP

This brand name is authorized in Austria, Germany, Croatia

Active ingredients

The drug LANITOP contains one active pharmaceutical ingredient (API):

1 Metildigoxin semiacetone
UNII I7GG1YUC5V - METILDIGOXIN

Metildigoxin, a methyl derivative of digoxin, is a cardiac glycoside a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia.

Read about Metildigoxin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01AA08 Metildigoxin C Cardiovascular system → C01 Cardiac therapy → C01A Cardiac glycosides → C01AA Digitalis glycosides
Discover more medicines within C01AA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut fĂźr Arzneimittel und Medizinprodukte Identifier(s): 01437555, 01437561, 02350773, 03032704, 03032710, 04959082, 08779247
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-278270858

Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈